Jeewan Profile
Key Indicators
- Authorised Capital ₹ 3.40 Cr
as on 04-07-2024
- Paid Up Capital ₹ 1.00 M
as on 04-07-2024
- Company Age 87 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 15.00 Cr
as on 04-07-2024
- Revenue -88.50%
(FY 2018)
- Profit -30.93%
(FY 2018)
- Ebitda -17.49%
(FY 2018)
- Net Worth -41.38%
(FY 2018)
- Total Assets -2.20%
(FY 2018)
About Jeewan
The Corporate was formerly known as Mukand Lal & Sons Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.40 Cr and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹15.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Nirajkumar Bajaj, Rajesh Shah, and Suketu Shah serve as directors at the Company.
- CIN/LLPIN
U51900MH1937PLC002724
- Company No.
002724
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Nov 1937
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jeewan?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirajkumar Bajaj  | Director | 14-Aug-1997 | Current |
| Rajesh Shah | Director | 16-Jun-2001 | Current |
| Suketu Shah | Director | 16-Jun-2001 | Current |
Financial Performance and Corporate Structure Insights of Jeewan.
Jeewan Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 88.5% decrease. The company also saw a substantial fall in profitability, with a 30.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jeewan?
In 2018, Jeewan had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Foundation For Promotion Of Sports And GamesActive 23 years 3 monthsNirajkumar Bajaj is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sun Pharma Laboratories Limited Creation Date: 12 Jun 2015 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Jeewan?
Jeewan has a workforce of 2 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeewan, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeewan's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
